First Command Bank’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CI
CM
First Command Bank's IBB Position: Q4 2017 in Review
First Command Bank sold out of iShares Biotechnology ETF (IBB) in Q4 2017, closing a stake of 81 shares — an estimated $9K sold.
First Command Bank first reported a position in IBB in Q4 2016 and held it in 4 quarters. The position peaked at $9K in Q3 2017. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.
- First Command Bank reported no remaining iShares Biotechnology ETF position as of Q4 2017 after selling out during the quarter.
- First Command Bank sold 81 iShares Biotechnology ETF shares in Q4 2017, an estimated $9K.
- First Command Bank first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 4 quarters.
- First Command Bank's iShares Biotechnology ETF position peaked at $9K in Q3 2017.
- 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.
Based on First Command Bank's 13F filing for Q4 2017, filed 12 Jan 2018.